Cargando…

Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma

MVI has significant clinical value for treatment selection and prognosis evaluation in hepatocellular carcinoma (HCC). We aimed to construct a model based on MVI-Related Genes (MVIRGs) for risk assessment and prognosis prediction in patients with HCC. This study utilized various statistical analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yongchang, Xu, Lei, Ren, Yupeng, Li, Yuxuan, Yuan, Feng, Cao, Mingbo, Zhang, Yong, Deng, Meihai, Yao, Zhicheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692135/ https://www.ncbi.nlm.nih.gov/pubmed/34975331 http://dx.doi.org/10.7150/ijbs.66536

Ejemplares similares

Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis
por: Yuan, Feng, et al.
Publicado: (2022)

Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis
por: Cao, Mingbo, et al.
Publicado: (2023)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma
por: Du, Min, et al.
Publicado: (2014)

The Salmonella typhimurium locus mviA regulates virulence in Itys but not Ityr mice: functional mviA results in avirulence; mutant (nonfunctional) mviA results in virulence
Publicado: (1991)

The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis
por: Yang, Jiarui, et al.
Publicado: (2021)

Contrast-enhanced CT findings-based model to predict MVI in patients with hepatocellular carcinoma
por: Yue, Qi, et al.
Publicado: (2022)

BDH2 is downregulated in hepatocellular carcinoma and acts as a tumor suppressor regulating cell apoptosis and autophagy
por: Liang, Hao, et al.
Publicado: (2019)

Efficacy of Adjuvant Transarterial Chemoembolization Combined Antiviral Therapy for HBV-Related HCC with MVI after Hepatic Resection: A Multicenter Study
por: Tang, Yupeng, et al.
Publicado: (2022)

Combining Preoperative Clinical and Imaging Characteristics to Predict MVI in Hepatitis B Virus-Related Combined Hepatocellular Carcinoma and Cholangiocarcinoma
por: Huang, Si-Si, et al.
Publicado: (2023)

MVI-TR: A Transformer-Based Deep Learning Model with Contrast-Enhanced CT for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
por: Cao, Linping, et al.
Publicado: (2023)

HI-MViT: A lightweight model for explainable skin disease classification based on modified MobileViT
por: Ding, Yuhan, et al.
Publicado: (2023)

A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation
por: Yang, Jiarui, et al.
Publicado: (2021)

Laparoscopic RFA with splenectomy for hepatocellular carcinoma
por: Hu, Kunpeng, et al.
Publicado: (2016)

Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
por: Xu, Jianliang, et al.
Publicado: (2019)

Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis
por: Liang, Hao, et al.
Publicado: (2018)

Phosphate Solubilizing Microorganism Bacillus sp. MVY-004 and Its Significance for Biomineral Fertilizers’ Development in Agrobiotechnology
por: Mažylytė, Raimonda, et al.
Publicado: (2022)

Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma
por: Yao, Zhicheng, et al.
Publicado: (2020)

Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma
por: Chen, Wenbiao, et al.
Publicado: (2020)

Optimizing the Growth Conditions of the Selected Plant-Growth-Promoting Rhizobacteria Paenibacillus sp. MVY-024 for Industrial Scale Production
por: Kaziūnienė, Justina, et al.
Publicado: (2022)

DNA Methylation Data-Based Classification and Identification of Prognostic Signature of Children With Wilms Tumor
por: Tang, Fucai, et al.
Publicado: (2021)

MVI-Mind: A Novel Deep-Learning Strategy Using Computed Tomography (CT)-Based Radiomics for End-to-End High Efficiency Prediction of Microvascular Invasion in Hepatocellular Carcinoma
por: Wang, Liyang, et al.
Publicado: (2022)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Identification and Validation of a Prognostic Model Based on Three Autophagy-Related Genes in Hepatocellular Carcinoma
por: Qin, Fanbo, et al.
Publicado: (2021)

Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma
por: Tu, Kangsheng, et al.
Publicado: (2021)

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)
por: McNeel, Douglas G, et al.
Publicado: (2022)

Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
por: Li, Binghua, et al.
Publicado: (2017)

Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
por: Chen, Yuqiao, et al.
Publicado: (2023)

Identification and Validation of Prognosis-Related Necroptosis Genes for Prognostic Prediction in Hepatocellular Carcinoma
por: Gao, Xin, et al.
Publicado: (2022)

Reducing Microvascular Dysfunction in Revascularized Patients with ST-Elevation Myocardial Infarction by Off-Target Properties of Ticagrelor versus Prasugrel. Rationale and Design of the REDUCE-MVI Study
por: Janssens, Gladys N., et al.
Publicado: (2016)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma
por: Yang, Huibin, et al.
Publicado: (2021)

Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma
por: Zhan, Ke, et al.
Publicado: (2021)

Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2020)

Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma
por: Zhang, Xi, et al.
Publicado: (2021)

Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma
por: Li, Zuyin, et al.
Publicado: (2022)

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma
por: Chen, Dan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_soc3cbv68j0qc0t2fe1g91v0ei